<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1"/><link rel="preload" href="/search/_next/static/media/47cbc4e2adbc5db9-s.p.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="preload" href="/search/_next/static/media/e4af272ccee01ff0-s.p.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="stylesheet" href="/search/_next/static/css/2c4d913f25bfc6bf.css" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" href="/search/_next/static/chunks/webpack-904c4041abd776f2.js"/><script src="/search/_next/static/chunks/4bd1b696-220750848fc52813.js" async=""></script><script src="/search/_next/static/chunks/1517-45045142ab33e6f1.js" async=""></script><script src="/search/_next/static/chunks/main-app-c0fb4dfbd302de72.js" async=""></script><script src="/search/_next/static/chunks/bc9e92e6-ca3f8a01cbc7cc31.js" async=""></script><script src="/search/_next/static/chunks/f71d1b72-799ff7a6833dc50c.js" async=""></script><script src="/search/_next/static/chunks/6586-1013c110456598c2.js" async=""></script><script src="/search/_next/static/chunks/4889-f0599128dd4090a0.js" async=""></script><script src="/search/_next/static/chunks/9141-d17bf49085d8e296.js" async=""></script><script src="/search/_next/static/chunks/2926-f97573e569b0b5d8.js" async=""></script><script src="/search/_next/static/chunks/8173-30737ce2fc776efb.js" async=""></script><script src="/search/_next/static/chunks/9756-90c6220c809c4148.js" async=""></script><script src="/search/_next/static/chunks/3163-d1a03f172499fcd8.js" async=""></script><script src="/search/_next/static/chunks/app/layout-802ca43371b3eb9d.js" async=""></script><script src="/search/_next/static/chunks/834cb1aa-fe75579b2a50baac.js" async=""></script><script src="/search/_next/static/chunks/2170a4aa-66be1631595ccab0.js" async=""></script><script src="/search/_next/static/chunks/1057-d97430463abd6821.js" async=""></script><script src="/search/_next/static/chunks/2282-26bc5318a4471ee9.js" async=""></script><script src="/search/_next/static/chunks/9234-fce85e807baa599f.js" async=""></script><script src="/search/_next/static/chunks/5733-d0ad15157d7394e5.js" async=""></script><script src="/search/_next/static/chunks/613-3467f3d6fe7e6e6a.js" async=""></script><script src="/search/_next/static/chunks/8738-58586275b0d791e8.js" async=""></script><script src="/search/_next/static/chunks/2649-8d5f655ba5d1c168.js" async=""></script><script src="/search/_next/static/chunks/1857-99747bd4076c313b.js" async=""></script><script src="/search/_next/static/chunks/2288-ffb609d77f258e27.js" async=""></script><script src="/search/_next/static/chunks/app/items/%5Bslug%5D/page-38377216d08118bc.js" async=""></script><link rel="preload" href="/search/_next/static/css/4921cfd18b262f8c.css" as="style"/><meta name="next-size-adjust" content=""/><meta name="emotion-insertion-point" content=""/><title>Genomics England - Bioinformatics</title><meta name="description" content="To identify and enrol participants for the 100,000 Genomes Project we have created NHS Genomic Medicine Centres (GMCs). Each centre includes several NHS Trusts and hospitals. GMCs recruit and consent patients. They then provide DNA samples and clinical information for analysis.

Illumina, a biotechnology company, have been commissioned to sequence the DNA of participants. They return the whole genome sequences to Genomics England. We have created a secure, monitored, infrastructure to store the genome sequences and clinical data. The data is analysed within this infrastructure and any important findings, like a diagnosis, are passed back to the patient’s doctor.

To help make sure that the project brings benefits for people who take part, we have created the Genomics England Clinical Interpretation Partnership (GeCIP). GeCIP brings together funders, researchers, NHS teams and trainees. They will analyse the data – to help ensure benefits for patients and an increased understanding of genomics. The data will also be used for medical and scientific research. This could be research into diagnosing, understanding or treating disease.

To learn more about how we work you can read the 100,000 Genomes Project protocol. It has details of the development, delivery and operation of the project. It also sets out the patient and clinical benefit, scientific and transformational objectives, the implementation strategy and the ethical and governance frameworks."/><meta property="og:title" content="Genomics England - Bioinformatics"/><meta property="og:description" content="To identify and enrol participants for the 100,000 Genomes Project we have created NHS Genomic Medicine Centres (GMCs). Each centre includes several NHS Trusts and hospitals. GMCs recruit and consent patients. They then provide DNA samples and clinical information for analysis.

Illumina, a biotechnology company, have been commissioned to sequence the DNA of participants. They return the whole genome sequences to Genomics England. We have created a secure, monitored, infrastructure to store the genome sequences and clinical data. The data is analysed within this infrastructure and any important findings, like a diagnosis, are passed back to the patient’s doctor.

To help make sure that the project brings benefits for people who take part, we have created the Genomics England Clinical Interpretation Partnership (GeCIP). GeCIP brings together funders, researchers, NHS teams and trainees. They will analyse the data – to help ensure benefits for patients and an increased understanding of genomics. The data will also be used for medical and scientific research. This could be research into diagnosing, understanding or treating disease.

To learn more about how we work you can read the 100,000 Genomes Project protocol. It has details of the development, delivery and operation of the project. It also sets out the patient and clinical benefit, scientific and transformational objectives, the implementation strategy and the ethical and governance frameworks."/><meta property="og:url" content="https://discoverynext.vercel.app/items/genomics-england-bioinformatics"/><meta property="og:site_name" content="Academic Resource Discovery"/><meta property="og:locale" content="en_US"/><meta property="og:image" content="https://harmonydata.ac.uk/search/harmony.png"/><meta property="og:image:width" content="1200"/><meta property="og:image:height" content="630"/><meta property="og:image:alt" content="Genomics England - Bioinformatics"/><meta property="og:type" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:title" content="Genomics England - Bioinformatics"/><meta name="twitter:description" content="To identify and enrol participants for the 100,000 Genomes Project we have created NHS Genomic Medicine Centres (GMCs). Each centre includes several NHS Trusts and hospitals. GMCs recruit and consent patients. They then provide DNA samples and clinical information for analysis.

Illumina, a biotechnology company, have been commissioned to sequence the DNA of participants. They return the whole genome sequences to Genomics England. We have created a secure, monitored, infrastructure to store the genome sequences and clinical data. The data is analysed within this infrastructure and any important findings, like a diagnosis, are passed back to the patient’s doctor.

To help make sure that the project brings benefits for people who take part, we have created the Genomics England Clinical Interpretation Partnership (GeCIP). GeCIP brings together funders, researchers, NHS teams and trainees. They will analyse the data – to help ensure benefits for patients and an increased understanding of genomics. The data will also be used for medical and scientific research. This could be research into diagnosing, understanding or treating disease.

To learn more about how we work you can read the 100,000 Genomes Project protocol. It has details of the development, delivery and operation of the project. It also sets out the patient and clinical benefit, scientific and transformational objectives, the implementation strategy and the ethical and governance frameworks."/><meta name="twitter:image" content="https://harmonydata.ac.uk/search/harmony.png"/><link rel="icon" href="/search/favicon.ico" type="image/x-icon" sizes="16x16"/><script src="/search/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule=""></script><style data-emotion="mui-global o39zl1">html{-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;box-sizing:border-box;-webkit-text-size-adjust:100%;}*,*::before,*::after{box-sizing:inherit;}strong,b{font-weight:700;}body{margin:0;color:#1A1A1A;font-size:0.875rem;line-height:1.5;font-family:'Roboto','Roboto Fallback';font-weight:400;background-color:#FFFFFF;}@media (min-width:600px){body{font-size:1rem;}}@media print{body{background-color:#fff;}}body::backdrop{background-color:#FFFFFF;}</style></head><body class="__className_62a302"><script src="/search/_next/static/chunks/webpack-904c4041abd776f2.js" async=""></script><script>(self.__next_f=self.__next_f||[]).push([0])</script><script>self.__next_f.push([1,"1:\"$Sreact.fragment\"\n2:I[82104,[\"2992\",\"static/chunks/bc9e92e6-ca3f8a01cbc7cc31.js\",\"9895\",\"static/chunks/f71d1b72-799ff7a6833dc50c.js\",\"6586\",\"static/chunks/6586-1013c110456598c2.js\",\"4889\",\"static/chunks/4889-f0599128dd4090a0.js\",\"9141\",\"static/chunks/9141-d17bf49085d8e296.js\",\"2926\",\"static/chunks/2926-f97573e569b0b5d8.js\",\"8173\",\"static/chunks/8173-30737ce2fc776efb.js\",\"9756\",\"static/chunks/9756-90c6220c809c4148.js\",\"3163\",\"static/chunks/3163-d1a03f172499fcd8.js\",\"7177\",\"static/chunks/app/layout-802ca43371b3eb9d.js\"],\"default\"]\n3:I[10683,[\"2992\",\"static/chunks/bc9e92e6-ca3f8a01cbc7cc31.js\",\"9895\",\"static/chunks/f71d1b72-799ff7a6833dc50c.js\",\"6586\",\"static/chunks/6586-1013c110456598c2.js\",\"4889\",\"static/chunks/4889-f0599128dd4090a0.js\",\"9141\",\"static/chunks/9141-d17bf49085d8e296.js\",\"2926\",\"static/chunks/2926-f97573e569b0b5d8.js\",\"8173\",\"static/chunks/8173-30737ce2fc776efb.js\",\"9756\",\"static/chunks/9756-90c6220c809c4148.js\",\"3163\",\"static/chunks/3163-d1a03f172499fcd8.js\",\"7177\",\"static/chunks/app/layout-802ca43371b3eb9d.js\"],\"AuthProvider\"]\n4:I[63612,[\"2992\",\"static/chunks/bc9e92e6-ca3f8a01cbc7cc31.js\",\"9895\",\"static/chunks/f71d1b72-799ff7a6833dc50c.js\",\"6586\",\"static/chunks/6586-1013c110456598c2.js\",\"4889\",\"static/chunks/4889-f0599128dd4090a0.js\",\"9141\",\"static/chunks/9141-d17bf49085d8e296.js\",\"2926\",\"static/chunks/2926-f97573e569b0b5d8.js\",\"8173\",\"static/chunks/8173-30737ce2fc776efb.js\",\"9756\",\"static/chunks/9756-90c6220c809c4148.js\",\"3163\",\"static/chunks/3163-d1a03f172499fcd8.js\",\"7177\",\"static/chunks/app/layout-802ca43371b3eb9d.js\"],\"SearchProvider\"]\n5:I[68998,[\"2992\",\"static/chunks/bc9e92e6-ca3f8a01cbc7cc31.js\",\"9895\",\"static/chunks/f71d1b72-799ff7a6833dc50c.js\",\"6586\",\"static/chunks/6586-1013c110456598c2.js\",\"4889\",\"static/chunks/4889-f0599128dd4090a0.js\",\"9141\",\"static/chunks/9141-d17bf49085d8e296.js\",\"2926\",\"static/chunks/2926-f97573e569b0b5d8.js\",\"8173\",\"static/chunks/8173-30737ce2fc776efb.js\",\"9756\",\"static/chunks/9756-90c6220c809c4148.js\",\"3163\",\"static/chunks/3163-d1a03f172499fcd8.js\",\"7177\",\"stati"])</script><script>self.__next_f.push([1,"c/chunks/app/layout-802ca43371b3eb9d.js\"],\"default\"]\n6:I[98904,[\"2992\",\"static/chunks/bc9e92e6-ca3f8a01cbc7cc31.js\",\"9895\",\"static/chunks/f71d1b72-799ff7a6833dc50c.js\",\"6586\",\"static/chunks/6586-1013c110456598c2.js\",\"4889\",\"static/chunks/4889-f0599128dd4090a0.js\",\"9141\",\"static/chunks/9141-d17bf49085d8e296.js\",\"2926\",\"static/chunks/2926-f97573e569b0b5d8.js\",\"8173\",\"static/chunks/8173-30737ce2fc776efb.js\",\"9756\",\"static/chunks/9756-90c6220c809c4148.js\",\"3163\",\"static/chunks/3163-d1a03f172499fcd8.js\",\"7177\",\"static/chunks/app/layout-802ca43371b3eb9d.js\"],\"default\"]\n7:I[15244,[],\"\"]\n8:I[43866,[],\"\"]\n9:I[14046,[\"2992\",\"static/chunks/bc9e92e6-ca3f8a01cbc7cc31.js\",\"9895\",\"static/chunks/f71d1b72-799ff7a6833dc50c.js\",\"6586\",\"static/chunks/6586-1013c110456598c2.js\",\"4889\",\"static/chunks/4889-f0599128dd4090a0.js\",\"9141\",\"static/chunks/9141-d17bf49085d8e296.js\",\"2926\",\"static/chunks/2926-f97573e569b0b5d8.js\",\"8173\",\"static/chunks/8173-30737ce2fc776efb.js\",\"9756\",\"static/chunks/9756-90c6220c809c4148.js\",\"3163\",\"static/chunks/3163-d1a03f172499fcd8.js\",\"7177\",\"static/chunks/app/layout-802ca43371b3eb9d.js\"],\"ToastContainer\"]\nb:I[86213,[],\"OutletBoundary\"]\nd:I[86213,[],\"MetadataBoundary\"]\nf:I[86213,[],\"ViewportBoundary\"]\n11:I[34835,[],\"\"]\n:HL[\"/search/_next/static/media/47cbc4e2adbc5db9-s.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n:HL[\"/search/_next/static/media/e4af272ccee01ff0-s.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n:HL[\"/search/_next/static/css/2c4d913f25bfc6bf.css\",\"style\"]\n:HL[\"/search/_next/static/css/4921cfd18b262f8c.css\",\"style\"]\n"])</script><script>self.__next_f.push([1,"0:{\"P\":null,\"b\":\"8r-g2-FTTcZL6JFFobnJN\",\"p\":\"/search\",\"c\":[\"\",\"items\",\"genomics-england-bioinformatics\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"items\",{\"children\":[[\"slug\",\"genomics-england-bioinformatics\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/search/_next/static/css/2c4d913f25bfc6bf.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"$undefined\"}]],[\"$\",\"html\",null,{\"lang\":\"en\",\"children\":[[\"$\",\"head\",null,{\"children\":[\"$\",\"meta\",null,{\"name\":\"emotion-insertion-point\",\"content\":\"\"}]}],[\"$\",\"body\",null,{\"className\":\"__className_62a302\",\"children\":[\"$\",\"$L2\",null,{\"children\":[\"$\",\"$L3\",null,{\"children\":[\"$\",\"$L4\",null,{\"children\":[[\"$\",\"$L5\",null,{\"sx\":{\"display\":\"flex\",\"flexDirection\":{\"xs\":\"column\",\"md\":\"row\"}},\"children\":[[\"$\",\"$L6\",null,{}],[\"$\",\"$L5\",null,{\"component\":\"main\",\"sx\":{\"flexGrow\":1,\"ml\":{\"xs\":0,\"md\":\"72px\"},\"mt\":{\"xs\":\"64px\",\"md\":0},\"minHeight\":{\"xs\":\"calc(100vh - 64px)\",\"md\":\"100vh\"},\"width\":{\"xs\":\"100%\",\"md\":\"calc(100% - 72px)\"}},\"children\":[\"$\",\"$L7\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\"],\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L8\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[],[[\"$\",\"title\",null,{\"children\":\"404: This page could not be found.\"}],[\"$\",\"div\",null,{\"style\":{\"fontFamily\":\"system-ui,\\\"Segoe UI\\\",Roboto,Helvetica,Arial,sans-serif,\\\"Apple Color Emoji\\\",\\\"Segoe UI Emoji\\\"\",\"height\":\"100vh\",\"textAlign\":\"center\",\"display\":\"flex\",\"flexDirection\":\"column\",\"alignItems\":\"center\",\"justifyContent\":\"center\"},\"children\":[\"$\",\"div\",null,{\"children\":[[\"$\",\"style\",null,{\"dangerouslySetInnerHTML\":{\"__html\":\"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}\"}}],[\"$\",\"h1\",null,{\"className\":\"next-error-h1\",\"style\":{\"display\":\"inline-block\",\"margin\":\"0 20px 0 0\",\"padding\":\"0 23px 0 0\",\"fontSize\":24,\"fontWeight\":500,\"verticalAlign\":\"top\",\"lineHeight\":\"49px\"},\"children\":404}],[\"$\",\"div\",null,{\"style\":{\"display\":\"inline-block\"},\"children\":[\"$\",\"h2\",null,{\"style\":{\"fontSize\":14,\"fontWeight\":400,\"lineHeight\":\"49px\",\"margin\":0},\"children\":\"This page could not be found.\"}]}]]}]}]]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]}]]}],[\"$\",\"$L9\",null,{\"position\":\"bottom-right\"}]]}]}]}]}]]}]]}],{\"children\":[\"items\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L7\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\",\"items\",\"children\"],\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L8\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"genomics-england-bioinformatics\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L7\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\",\"items\",\"children\",\"$0:f:0:1:2:children:2:children:0\",\"children\"],\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L8\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$La\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/search/_next/static/css/4921cfd18b262f8c.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"$undefined\"}]],[\"$\",\"$Lb\",null,{\"children\":\"$Lc\"}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[\"$\",\"$1\",\"7EeWpmeBgS9ejROWKg0yN\",{\"children\":[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"$Lf\",null,{\"children\":\"$L10\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$11\",\"$undefined\"],\"s\":false,\"S\":true}\n"])</script><script>self.__next_f.push([1,"10:[[\"$\",\"meta\",\"0\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1\"}]]\n"])</script><script>self.__next_f.push([1,"13:I[5749,[\"2992\",\"static/chunks/bc9e92e6-ca3f8a01cbc7cc31.js\",\"9895\",\"static/chunks/f71d1b72-799ff7a6833dc50c.js\",\"2154\",\"static/chunks/834cb1aa-fe75579b2a50baac.js\",\"3524\",\"static/chunks/2170a4aa-66be1631595ccab0.js\",\"6586\",\"static/chunks/6586-1013c110456598c2.js\",\"4889\",\"static/chunks/4889-f0599128dd4090a0.js\",\"1057\",\"static/chunks/1057-d97430463abd6821.js\",\"2282\",\"static/chunks/2282-26bc5318a4471ee9.js\",\"9234\",\"static/chunks/9234-fce85e807baa599f.js\",\"9141\",\"static/chunks/9141-d17bf49085d8e296.js\",\"2926\",\"static/chunks/2926-f97573e569b0b5d8.js\",\"5733\",\"static/chunks/5733-d0ad15157d7394e5.js\",\"8173\",\"static/chunks/8173-30737ce2fc776efb.js\",\"613\",\"static/chunks/613-3467f3d6fe7e6e6a.js\",\"9756\",\"static/chunks/9756-90c6220c809c4148.js\",\"8738\",\"static/chunks/8738-58586275b0d791e8.js\",\"2649\",\"static/chunks/2649-8d5f655ba5d1c168.js\",\"1857\",\"static/chunks/1857-99747bd4076c313b.js\",\"2288\",\"static/chunks/2288-ffb609d77f258e27.js\",\"6387\",\"static/chunks/app/items/%5Bslug%5D/page-38377216d08118bc.js\"],\"default\"]\n12:Tebe,"])</script><script>self.__next_f.push([1,"{\"@context\":\"https://schema.org/\",\"@type\":\"Dataset\",\"name\":\"Genomics England - Bioinformatics\",\"description\":\"To identify and enrol participants for the 100,000 Genomes Project we have created NHS Genomic Medicine Centres (GMCs). Each centre includes several NHS Trusts and hospitals. GMCs recruit and consent patients. They then provide DNA samples and clinical information for analysis.\\r\\n\\r\\nIllumina, a biotechnology company, have been commissioned to sequence the DNA of participants. They return the whole genome sequences to Genomics England. We have created a secure, monitored, infrastructure to store the genome sequences and clinical data. The data is analysed within this infrastructure and any important findings, like a diagnosis, are passed back to the patient’s doctor.\\r\\n\\r\\nTo help make sure that the project brings benefits for people who take part, we have created the Genomics England Clinical Interpretation Partnership (GeCIP). GeCIP brings together funders, researchers, NHS teams and trainees. They will analyse the data – to help ensure benefits for patients and an increased understanding of genomics. The data will also be used for medical and scientific research. This could be research into diagnosing, understanding or treating disease.\\r\\n\\r\\nTo learn more about how we work you can read the 100,000 Genomes Project protocol. It has details of the development, delivery and operation of the project. It also sets out the patient and clinical benefit, scientific and transformational objectives, the implementation strategy and the ethical and governance frameworks.\",\"url\":\"https://discoverynext.vercel.app/items/genomics-england-bioinformatics\",\"keywords\":[\"Data\",\"Genomics\",\"DATA-CAN\",\"Sequencing\",\"DNA\"],\"identifier\":[],\"variableMeasured\":[{\"name\":\"aggregate_gvcf_sample_stats\",\"description\":\"A unique ID assigned to every genome delivery\"},{\"name\":\"cancer_100K_genomes_realigned_on_pipeline_2\",\"description\":\"The file path to the germline copy number variant VCF\"},{\"name\":\"cancer_staging_consolidated\",\"description\":\"[cancer_participant_tumour] AJCC STAGE GROUP, not the UICC TNM Stage Grouping, should be collected for stageable skin cancers. American Joint Committee on Cancer staging of tumour at diagnosis. This is the final integrated stage as agreed by MDT. See COSD User Guide for site specific options.\"},{\"name\":\"cancer_tier_and_domain_variants\",\"description\":\"rare disease or cancer program\"},{\"name\":\"denovo_cohort_information\",\"description\":\"The person’s disease status with respect to rare disease.\"},{\"name\":\"denovo_flagged_variants\",\"description\":\"Does the variant pass the abratio_filter (0: NO, 1: YES)\"},{\"name\":\"domain_assignment\",\"description\":\"Date at which publication moratorium on participant ends\"},{\"name\":\"exomiser\",\"description\":\"alternate: Alternate Allele sequence, the same provided in vcf\"},{\"name\":\"genome_file_paths_and_types\",\"description\":\"The date the genome was delivered\"},{\"name\":\"gmc_exit_questionnaire\",\"description\":\"What ACMG pathogenicity score (1-5) did you assign to this variant?\"},{\"name\":\"panels_applied\",\"description\":\"A unique identifier for a group of participants or genomes who are interpreted together. For rare disease this will be a family and for cancer this will be a tumour-normal pair.\"},{\"name\":\"submitted_diagnostic_discovery\",\"description\":\"Participant Identifier (supplied by Genomics England)\"},{\"name\":\"tiered_variants_frequency\",\"description\":\"Allele frequency of variant in the specific dataset.\"}],\"includedInDataCatalog\":[{\"@type\":\"DataCatalog\",\"name\":\"Health Data Research Innovation Gateway\",\"url\":\"https://healthdatagateway.org/en/dataset/381\"}],\"publisher\":[{\"@type\":\"Organization\",\"name\":\"Genomics England\"}],\"temporalCoverage\":\"2014-01-01/2019-01-01\"}"])</script><script>self.__next_f.push([1,"14:T5c9,To identify and enrol participants for the 100,000 Genomes Project we have created NHS Genomic Medicine Centres (GMCs). Each centre includes several NHS Trusts and hospitals. GMCs recruit and consent patients. They then provide DNA samples and clinical information for analysis.\r\n\r\nIllumina, a biotechnology company, have been commissioned to sequence the DNA of participants. They return the whole genome sequences to Genomics England. We have created a secure, monitored, infrastructure to store the genome sequences and clinical data. The data is analysed within this infrastructure and any important findings, like a diagnosis, are passed back to the patient’s doctor.\r\n\r\nTo help make sure that the project brings benefits for people who take part, we have created the Genomics England Clinical Interpretation Partnership (GeCIP). GeCIP brings together funders, researchers, NHS teams and trainees. They will analyse the data – to help ensure benefits for patients and an increased understanding of genomics. The data will also be used for medical and scientific research. This could be research into diagnosing, understanding or treating disease.\r\n\r\nTo learn more about how we work you can read the 100,000 Genomes Project protocol. It has details of the development, delivery and operation of the project. It also sets out the patient and clinical benefit, scientific and transformational objectives, the implementation strategy and the ethical and governance frameworks."])</script><script>self.__next_f.push([1,"a:[[\"$\",\"script\",null,{\"type\":\"application/ld+json\",\"dangerouslySetInnerHTML\":{\"__html\":\"$12\"}}],[\"$\",\"$L13\",null,{\"dataset\":{\"title\":\"Genomics England - Bioinformatics\",\"description\":\"$14\",\"image\":\"$undefined\",\"publisher\":{\"name\":\"Genomics England\",\"url\":\"$undefined\",\"logo\":\"$undefined\"},\"funders\":\"$undefined\",\"geographicCoverage\":\"GB\",\"temporalCoverage\":\"2014-01-01/2019-01-01\",\"ageCoverage\":\"$undefined\",\"studyDesign\":[],\"resourceType\":\"dataset\",\"topics\":[\"Data\",\"Genomics\",\"DATA-CAN\",\"Sequencing\",\"DNA\"],\"instruments\":[],\"dataCatalogs\":[{\"name\":\"Health Data Research Innovation Gateway\",\"url\":\"https://healthdatagateway.org/en/dataset/381\",\"logo\":\"$undefined\"}],\"matchedVariables\":[],\"allVariables\":[{\"name\":\"aggregate_gvcf_sample_stats\",\"description\":\"A unique ID assigned to every genome delivery\"},{\"name\":\"cancer_100K_genomes_realigned_on_pipeline_2\",\"description\":\"The file path to the germline copy number variant VCF\"},{\"name\":\"cancer_staging_consolidated\",\"description\":\"[cancer_participant_tumour] AJCC STAGE GROUP, not the UICC TNM Stage Grouping, should be collected for stageable skin cancers. American Joint Committee on Cancer staging of tumour at diagnosis. This is the final integrated stage as agreed by MDT. See COSD User Guide for site specific options.\"},{\"name\":\"cancer_tier_and_domain_variants\",\"description\":\"rare disease or cancer program\"},{\"name\":\"denovo_cohort_information\",\"description\":\"The person’s disease status with respect to rare disease.\"},{\"name\":\"denovo_flagged_variants\",\"description\":\"Does the variant pass the abratio_filter (0: NO, 1: YES)\"},{\"name\":\"domain_assignment\",\"description\":\"Date at which publication moratorium on participant ends\"},{\"name\":\"exomiser\",\"description\":\"alternate: Alternate Allele sequence, the same provided in vcf\"},{\"name\":\"genome_file_paths_and_types\",\"description\":\"The date the genome was delivered\"},{\"name\":\"gmc_exit_questionnaire\",\"description\":\"What ACMG pathogenicity score (1-5) did you assign to this variant?\"},{\"name\":\"panels_applied\",\"description\":\"A unique identifier for a group of participants or genomes who are interpreted together. For rare disease this will be a family and for cancer this will be a tumour-normal pair.\"},{\"name\":\"submitted_diagnostic_discovery\",\"description\":\"Participant Identifier (supplied by Genomics England)\"},{\"name\":\"tiered_variants_frequency\",\"description\":\"Allele frequency of variant in the specific dataset.\"}],\"additionalLinks\":[\"https://healthdatagateway.org/en/dataset/381\"],\"child_datasets\":[],\"aiSummary\":null}}]]\n"])</script><script>self.__next_f.push([1,"15:T5c9,To identify and enrol participants for the 100,000 Genomes Project we have created NHS Genomic Medicine Centres (GMCs). Each centre includes several NHS Trusts and hospitals. GMCs recruit and consent patients. They then provide DNA samples and clinical information for analysis.\r\n\r\nIllumina, a biotechnology company, have been commissioned to sequence the DNA of participants. They return the whole genome sequences to Genomics England. We have created a secure, monitored, infrastructure to store the genome sequences and clinical data. The data is analysed within this infrastructure and any important findings, like a diagnosis, are passed back to the patient’s doctor.\r\n\r\nTo help make sure that the project brings benefits for people who take part, we have created the Genomics England Clinical Interpretation Partnership (GeCIP). GeCIP brings together funders, researchers, NHS teams and trainees. They will analyse the data – to help ensure benefits for patients and an increased understanding of genomics. The data will also be used for medical and scientific research. This could be research into diagnosing, understanding or treating disease.\r\n\r\nTo learn more about how we work you can read the 100,000 Genomes Project protocol. It has details of the development, delivery and operation of the project. It also sets out the patient and clinical benefit, scientific and transformational objectives, the implementation strategy and the ethical and governance frameworks.16:T5c9,To identify and enrol participants for the 100,000 Genomes Project we have created NHS Genomic Medicine Centres (GMCs). Each centre includes several NHS Trusts and hospitals. GMCs recruit and consent patients. They then provide DNA samples and clinical information for analysis.\r\n\r\nIllumina, a biotechnology company, have been commissioned to sequence the DNA of participants. They return the whole genome sequences to Genomics England. We have created a secure, monitored, infrastructure to store the genome sequences and clinical data. The data is a"])</script><script>self.__next_f.push([1,"nalysed within this infrastructure and any important findings, like a diagnosis, are passed back to the patient’s doctor.\r\n\r\nTo help make sure that the project brings benefits for people who take part, we have created the Genomics England Clinical Interpretation Partnership (GeCIP). GeCIP brings together funders, researchers, NHS teams and trainees. They will analyse the data – to help ensure benefits for patients and an increased understanding of genomics. The data will also be used for medical and scientific research. This could be research into diagnosing, understanding or treating disease.\r\n\r\nTo learn more about how we work you can read the 100,000 Genomes Project protocol. It has details of the development, delivery and operation of the project. It also sets out the patient and clinical benefit, scientific and transformational objectives, the implementation strategy and the ethical and governance frameworks.17:T5c9,To identify and enrol participants for the 100,000 Genomes Project we have created NHS Genomic Medicine Centres (GMCs). Each centre includes several NHS Trusts and hospitals. GMCs recruit and consent patients. They then provide DNA samples and clinical information for analysis.\r\n\r\nIllumina, a biotechnology company, have been commissioned to sequence the DNA of participants. They return the whole genome sequences to Genomics England. We have created a secure, monitored, infrastructure to store the genome sequences and clinical data. The data is analysed within this infrastructure and any important findings, like a diagnosis, are passed back to the patient’s doctor.\r\n\r\nTo help make sure that the project brings benefits for people who take part, we have created the Genomics England Clinical Interpretation Partnership (GeCIP). GeCIP brings together funders, researchers, NHS teams and trainees. They will analyse the data – to help ensure benefits for patients and an increased understanding of genomics. The data will also be used for medical and scientific research. This could be research into d"])</script><script>self.__next_f.push([1,"iagnosing, understanding or treating disease.\r\n\r\nTo learn more about how we work you can read the 100,000 Genomes Project protocol. It has details of the development, delivery and operation of the project. It also sets out the patient and clinical benefit, scientific and transformational objectives, the implementation strategy and the ethical and governance frameworks.e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"title\",\"1\",{\"children\":\"Genomics England - Bioinformatics\"}],[\"$\",\"meta\",\"2\",{\"name\":\"description\",\"content\":\"$15\"}],[\"$\",\"meta\",\"3\",{\"property\":\"og:title\",\"content\":\"Genomics England - Bioinformatics\"}],[\"$\",\"meta\",\"4\",{\"property\":\"og:description\",\"content\":\"$16\"}],[\"$\",\"meta\",\"5\",{\"property\":\"og:url\",\"content\":\"https://discoverynext.vercel.app/items/genomics-england-bioinformatics\"}],[\"$\",\"meta\",\"6\",{\"property\":\"og:site_name\",\"content\":\"Academic Resource Discovery\"}],[\"$\",\"meta\",\"7\",{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:image\",\"content\":\"https://harmonydata.ac.uk/search/harmony.png\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:image:width\",\"content\":\"1200\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:image:height\",\"content\":\"630\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:image:alt\",\"content\":\"Genomics England - Bioinformatics\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",\"13\",{\"name\":\"twitter:card\",\"content\":\"summary_large_image\"}],[\"$\",\"meta\",\"14\",{\"name\":\"twitter:title\",\"content\":\"Genomics England - Bioinformatics\"}],[\"$\",\"meta\",\"15\",{\"name\":\"twitter:description\",\"content\":\"$17\"}],[\"$\",\"meta\",\"16\",{\"name\":\"twitter:image\",\"content\":\"https://harmonydata.ac.uk/search/harmony.png\"}],[\"$\",\"link\",\"17\",{\"rel\":\"icon\",\"href\":\"/search/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}]]\nc:null\n"])</script></body></html>